AIM ImmunoTech Inc

NYSE American: AIM
Share price (8/14/25): $2.57
Market cap (8/14/25): $1.964 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Initial registration of new securities – amended

Registration of securities for employees

Initial registration of new securities – amended

Shelf registration – amended

Ownership Filter

Equels Thomas K

Equels Thomas K

Mitchell William M

Equels Thomas K

News Filter

Announces Closing of $8.0 Million Public Offering

Reports Positive Mid-Year Safety and Efficacy Data From Phase 2 Study Evaluating Ampligen® (Rintatolimod) in Combination With AstraZeneca’s Imfinzi® (Durvalumab) for the Treatment of Pancreatic Cancer

Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements

Announces 1-For-100 Reverse Stock Split

Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Proxy materials by non-management

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC